User profiles for Emilia Roy-Vallejo

Emilia Roy Vallejo

Hospital Universitario de La Princesa
Verified email at salud.madrid.org
Cited by 1090

IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study

…, SC Rodríguez-García, E Roy-Vallejo… - Journal of Allergy and …, 2021 - Elsevier
Background Patients with coronavirus disaese 2019 (COVID-19) can develop a cytokine
release syndrome that eventually leads to acute respiratory distress syndrome requiring …

[HTML][HTML] A differential signature of circulating miRNAs and cytokines between COVID-19 and community-acquired pneumonia uncovers novel physiopathological …

…, S Requena, E Roy-Vallejo… - Frontiers in …, 2022 - frontiersin.org
Coronavirus Disease 2019 (COVID-19) pneumonia is a life-threatening infectious disease,
especially for elderly patients with multiple comorbidities. Despite enormous efforts to …

[HTML][HTML] Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients

DA Rodríguez-Serrano, E Roy-Vallejo… - Scientific Reports, 2021 - nature.com
COVID-19 has overloaded national health services worldwide. Thus, early identification of
patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA …

[HTML][HTML] Beneficial effect of temporary methotrexate interruption on B and T cell responses upon SARS-CoV-2 vaccination in patients with rheumatoid arthritis or …

…, A Triguero-Martínez, E Roy-Vallejo… - npj Vaccines, 2024 - nature.com
B and T cell responses were evaluated in patients with rheumatoid arthritis (RA) or psoriatic
arthritis (PsA) after 1 or 2 weeks of methotrexate (MTX) withdrawal following each COVID-19 …

[HTML][HTML] Advances in the treatment of giant cell arteritis

…, A Triguero-Martínez, E Roy-Vallejo… - Journal of clinical …, 2022 - mdpi.com
Giant cell arteritis (GCA) is the most common vasculitis among elderly people. The clinical
spectrum of the disease is heterogeneous, with a classic/cranial phenotype, and another …

Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Network

…, C Lumbreras, JMR Rincón, E Roy-Vallejo… - MedRxiv, 2020 - medrxiv.org
Background Spain has been one of the countries most affected by the COVID-19 pandemic.
Objective To create a registry of patients with COVID-19 hospitalized in Spain in order to …

Relevant SARS‐CoV‐2 viremia is associated with COVID‐19 severity: Prospective cohort study and validation cohort

L Cardeñoso Domingo, E Roy Vallejo… - Journal of Medical …, 2022 - Wiley Online Library
Early kinetics of SARS‐CoV‐2 viral load (VL) in plasma determined by quantitative reverse‐transcription
polymerase chain reaction (RT‐PCR) was evaluated as a predictor of poor …

[HTML][HTML] Risk categories in COVID-19 based on degrees of inflammation: data on more than 17,000 patients from the Spanish SEMI-COVID-19 Registry

…, A Lalueza, A Parra Virto, E Roy Vallejo… - Journal of Clinical …, 2021 - mdpi.com
(1) Background: The inflammation or cytokine storm that accompanies COVID-19 marks the
prognosis. This study aimed to identify three risk categories based on inflammatory …

[HTML][HTML] Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients …

…, H Vilchez-Rueda, A Lalueza, E Roy-Vallejo… - PLoS …, 2022 - journals.plos.org
Background Valproic acid (VPA) has shown beneficial effects in vitro against SARS-CoV-2
infection, but no study has analyzed its efficacy in the clinical setting. Methods This multicenter…

[HTML][HTML] SARS-CoV-2 viremia precedes an IL6 response in severe COVID-19 patients: results of a longitudinal prospective cohort

E Roy-Vallejo, L Cardeñoso… - Frontiers in …, 2022 - frontiersin.org
Background: Interleukin 6 (IL6) levels and SARS-CoV-2 viremia have been correlated with
COVID-19 severity. The association over time between them has not been assessed in a …